
#Medchem @merckgroup former @bayerpharma interested in #cancer #kinaseinhibitors #degraders only personal views Reviewer @drughunter
Darmstadt, Germany
Joined November 2017
- Tweets923
- Following580
- Followers899
- Likes2.7K
Very nice to be back in Bristol for the CDT Summer Conference. A lot of great science presented by very talented PhD students ! Congratulations to @JonathanClayden, @VarinderAggar11 and @BCS_CDT
I keep being amazed by the work from @Rev_Medicine Here is a example from their last patent. This work is again pushing medicinal chemistry out of out comfort zone. 6 chiral centers, 1 atropisomer , a spiro and an aziridine ! Congratulations to @Les_Burnett and all the Team!
Final Session for the New drugs on the horizon @aacr #AACR23. SMOLs, molecular glue, ADC. @MerckHealthcare @MonteRosaTx @elevationonc @TangoTxOncology
Excellent second session for New Drugs on the horizon !! @AACR #aacr23. Degrader, bi-specific antibody, molecular glue, and covalent inhibitor !! @C4Therapeutics @Amgen @Rev_Medicine Flare Therapeutics !
Let s start the second day #AACR2023 with a very exciting educational on degraders @danetteldaniels @ChrisNasveschuk @FleurMFerguson
Excellent way to finish the day yesterday at #FIMC2023 @GDCh_aktuell . What a performance from @DirkTrauner with a journey in photopharmacology and natural product synthesis.
12
1,152
Great scientific talks in the #NextGenMedChem session at #fimc2023 with Stefanie Flohr @Novartis @crwfrd_SF @genentech and Sophie Bertrand @gsk
More science from the #NextGenMedChem ! Excelletalk from @Franca_klg !
Replying to @ThornSesholdLab
5
149
let s start Day 2 #FIMC2023 with @georg_e_winter !! @GDCh_aktuell
My colleague Andreas @MerckHealthcare now on stage at the #FIMC2023 @GDCh_aktuell
First PI3K inhibitor approved outside oncology ! Pharming’s Leniolosib is the first treatment approved by the @US_FDA for APDS. Great news for patients ! Congrats to colleagues @Novartis for this discovery.
pharming.com/news/pharming-a…
Check out this great article from my colleagues @MerckHealthcare on the discovery of the highly mutant selective KIT inhibitor M4205 ! Excellent work driven by clinical need ! #VibrantMedChem #VibrantChemistry @merckgroup @ACSBioMed
pubs.acs.org/doi/full/10.102…
14
1,448










































